{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:57:09Z","timestamp":1788893829790,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T00:00:00Z","timestamp":1275523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T00:00:00Z","timestamp":1275523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1038\/leu.2010.118","type":"journal-article","created":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T09:44:20Z","timestamp":1275558260000},"page":"1487-1497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Differential expression of NF-\u03baB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism"],"prefix":"10.1038","volume":"24","author":[{"given":"R A","family":"Hamoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Appert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ruskone-Fourmestraux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Streubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Raderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Wlodarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"De Wolf-Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K A","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P G","family":"Isaacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-Q","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,3]]},"reference":[{"key":"BFleu2010118_CR1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrc1409","volume":"4","author":"PG Isaacson","year":"2004","unstructured":"Isaacson PG, Du MQ . MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4: 644\u2013653.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2010118_CR2","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1182\/blood-2002-11-3502","volume":"102","author":"H Ye","year":"2003","unstructured":"Ye H, Liu H, Attygalle A, Wotherspoon AC, Nicholson AG, Charlotte F et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 2003; 102: 1012\u20131018.","journal-title":"Blood"},{"key":"BFleu2010118_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/path.1715","volume":"205","author":"H Ye","year":"2005","unstructured":"Ye H, Gong L, Liu H, Hamoudi RA, Shirali S, Ho L et al. MALT lymphoma with t(14;18)(q32;q21)\/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J Pathol 2005; 205: 293\u2013301.","journal-title":"J Pathol"},{"key":"BFleu2010118_CR4","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","volume":"18","author":"B Streubel","year":"2004","unstructured":"Streubel B, Simonitsch-Klupp I, Mullauer L, Lamprecht A, Huber D, Siebert R et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004; 18: 1722\u20131726.","journal-title":"Leukemia"},{"key":"BFleu2010118_CR5","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/modpathol.2008.74","volume":"21","author":"A Goatly","year":"2008","unstructured":"Goatly A, Bacon CM, Nakamura S, Ye H, Kim I, Brown PJ et al. FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control. Mod Pathol 2008; 21: 902\u2013911.","journal-title":"Mod Pathol"},{"key":"BFleu2010118_CR6","doi-asserted-by":"publisher","first-page":"19012","DOI":"10.1074\/jbc.M009984200","volume":"276","author":"PC Lucas","year":"2001","unstructured":"Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF et al. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 2001; 276: 19012\u201319019.","journal-title":"J Biol Chem"},{"key":"BFleu2010118_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nature02273","volume":"427","author":"H Zhou","year":"2004","unstructured":"Zhou H, Wertz I, O\u2019Rourke K, Ultsch M, Seshagiri S, Eby M et al. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 2004; 427: 167\u2013171.","journal-title":"Nature"},{"key":"BFleu2010118_CR8","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1038\/sj.onc.1210342","volume":"26","author":"PC Lucas","year":"2007","unstructured":"Lucas PC, Kuffa P, Gu S, Kohrt D, Kim DS, Siu K et al. A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment. Oncogene 2007; 26: 5643\u20135654.","journal-title":"Oncogene"},{"key":"BFleu2010118_CR9","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1158\/0008-5472.CAN-05-4590","volume":"66","author":"M Baens","year":"2006","unstructured":"Baens M, Fevery S, Sagaert X, Noels H, Hagens S, Broeckx V et al. Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination. Cancer Res 2006; 66: 5270\u20135277.","journal-title":"Cancer Res"},{"key":"BFleu2010118_CR10","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1182\/blood-2008-12-192583","volume":"114","author":"Z Li","year":"2009","unstructured":"Li Z, Wang H, Xue L, Shin DM, Roopenian D, Xu W et al. Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma. Blood 2009; 114: 4158\u20134168.","journal-title":"Blood"},{"key":"BFleu2010118_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2141.2006.05969.x","volume":"133","author":"Y Zhou","year":"2006","unstructured":"Zhou Y, Ye H, Martin-Subero JI, Hamoudi R, Lu YJ, Wang R et al. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21). Br J Haematol 2006; 133: 35\u201342.","journal-title":"Br J Haematol"},{"key":"BFleu2010118_CR12","first-page":"1693","volume":"91","author":"X Sagaert","year":"2006","unstructured":"Sagaert X, Theys T, Wolf-Peeters C, Marynen P, Baens M . Splenic marginal zone lymphoma-like features in API2-MALT1 transgenic mice that are exposed to antigenic stimulation. Haematologica 2006; 91: 1693\u20131696.","journal-title":"Haematologica"},{"key":"BFleu2010118_CR13","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1182\/blood-2004-06-2297","volume":"105","author":"L Ho","year":"2005","unstructured":"Ho L, Davis RE, Conne B, Chappuis R, Berczy M, Mhawech P et al. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood 2005; 105: 2891\u20132899.","journal-title":"Blood"},{"key":"BFleu2010118_CR14","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1053\/gast.2002.33047","volume":"122","author":"H Liu","year":"2002","unstructured":"Liu H, Ye H, Ruskone-Fourmestraux A, de Jong D, Pileri S, Thiede C et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H pylori eradication. Gastroenterology 2002; 122: 1286\u20131294.","journal-title":"Gastroenterology"},{"key":"BFleu2010118_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/gut.2005.081117","volume":"55","author":"H Ye","year":"2006","unstructured":"Ye H, Gong L, Liu H, Ruskone-Fourmestraux A, de Jong D, Pileri S et al. Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication. Gut 2006; 55: 137\u2013138.","journal-title":"Gut"},{"key":"BFleu2010118_CR16","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0002-9440(10)63908-9","volume":"162","author":"M Okabe","year":"2003","unstructured":"Okabe M, Inagaki H, Ohshima K, Yoshino T, Li C, Eimoto T et al. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Pathol 2003; 162: 1113\u20131122.","journal-title":"Am J Pathol"},{"key":"BFleu2010118_CR17","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545\u201315550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2010118_CR18","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1093\/nar\/gkl766","volume":"34","author":"V Saxena","year":"2006","unstructured":"Saxena V, Orgill D, Kohane I . Absolute enrichment: gene set enrichment analysis for homeostatic systems. Nucleic Acids Res 2006; 34: e151.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2010118_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cellimm.2007.01.012","volume":"244","author":"C Ortutay","year":"2006","unstructured":"Ortutay C, Vihinen M . Immunome: a reference set of genes and proteins for systems biology of the human immune system. Cell Immunol 2006; 244: 87\u201389.","journal-title":"Cell Immunol"},{"key":"BFleu2010118_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/1471-2105-8-273","volume":"8","author":"SD Pepper","year":"2007","unstructured":"Pepper SD, Saunders EK, Edwards LE, Wilson CL, Miller CJ . The utility of MAS5 expression summary and detection call algorithms. BMC Bioinformatics 2007; 8: 273.","journal-title":"BMC Bioinformatics"},{"key":"BFleu2010118_CR21","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.peptides.2007.07.005","volume":"28","author":"RP Gomariz","year":"2007","unstructured":"Gomariz RP, Arranz A, Juarranz Y, Gutierrez-Canas I, Garcia-Gomez M, Leceta J et al. Regulation of TLR expression, a new perspective for the role of VIP in immunity. Peptides 2007; 28: 1825\u20131832.","journal-title":"Peptides"},{"key":"BFleu2010118_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1182\/blood-2008-02-140996","volume":"113","author":"WJ Chng","year":"2009","unstructured":"Chng WJ, Remstein ED, Fonseca R, Bergsagel PL, Vrana JA, Kurtin PJ et al. Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications. Blood 2009; 113: 635\u2013645.","journal-title":"Blood"},{"key":"BFleu2010118_CR23","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.4049\/jimmunol.180.6.3882","volume":"180","author":"AV Rubtsov","year":"2008","unstructured":"Rubtsov AV, Swanson CL, Troy S, Strauch P, Pelanda R, Torres RM . TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses. J Immunol 2008; 180: 3882\u20133888.","journal-title":"J Immunol"},{"key":"BFleu2010118_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K . Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499\u2013511.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2010118_CR25","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.4049\/jimmunol.175.11.7162","volume":"175","author":"T Ohmae","year":"2005","unstructured":"Ohmae T, Hirata Y, Maeda S, Shibata W, Yanai A, Ogura K et al. Helicobacter pylori activates NF-kappaB via the alternative pathway in B lymphocytes. J Immunol 2005; 175: 7162\u20137169.","journal-title":"J Immunol"},{"key":"BFleu2010118_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1574-695X.2007.00288.x","volume":"51","author":"S Yokota","year":"2007","unstructured":"Yokota S, Ohnishi T, Muroi M, Tanamoto K, Fujii N, Amano K . Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Toll-like receptor 4 complex. FEMS Immunol Med Microbiol 2007; 51: 140\u2013148.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"BFleu2010118_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.it.2004.12.006","volume":"26","author":"D Sancho","year":"2005","unstructured":"Sancho D, Gomez M, Sanchez-Madrid F . CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 2005; 26: 136\u2013140.","journal-title":"Trends Immunol"},{"key":"BFleu2010118_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-0609.1998.tb01009.x","volume":"60","author":"M Erlanson","year":"1998","unstructured":"Erlanson M, Gronlund E, Lofvenberg E, Roos G, Lindh J . Expression of activation markers CD23 and CD69 in B-cell non-Hodgkin's lymphoma. Eur J Haematol 1998; 60: 125\u2013132.","journal-title":"Eur J Haematol"},{"key":"BFleu2010118_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3324\/haematol.13574","volume":"94","author":"D de Jong","year":"2009","unstructured":"de Jong D, Koster A, Hagenbeek A, Raemaekers J, Veldhuizen D, Heisterkamp S et al. Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica 2009; 94: 70\u201377.","journal-title":"Haematologica"},{"key":"BFleu2010118_CR30","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1182\/blood-2006-03-013532","volume":"109","author":"UE Hopken","year":"2007","unstructured":"Hopken UE, Wengner AM, Loddenkemper C, Stein H, Heimesaat MM, Rehm A et al. CCR7 deficiency causes ectopic lymphoid neogenesis and disturbed mucosal tissue integrity. Blood 2007; 109: 886\u2013895.","journal-title":"Blood"},{"key":"BFleu2010118_CR31","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1084\/jem.20041185","volume":"200","author":"Y Nie","year":"2004","unstructured":"Nie Y, Waite J, Brewer F, Sunshine MJ, Littman DR, Zou YR . The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J Exp Med 2004; 200: 1145\u20131156.","journal-title":"J Exp Med"},{"key":"BFleu2010118_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cytogfr.2005.05.005","volume":"16","author":"JY Springael","year":"2005","unstructured":"Springael JY, Urizar E, Parmentier M . Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev 2005; 16: 611\u2013623.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFleu2010118_CR33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1189\/jlb.1203652","volume":"76","author":"S Lopez-Giral","year":"2004","unstructured":"Lopez-Giral S, Quintana NE, Cabrerizo M, Alfonso-Perez M, Sala-Valdes M, De Soria VG et al. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J Leukoc Biol 2004; 76: 462\u2013471.","journal-title":"J Leukoc Biol"},{"key":"BFleu2010118_CR34","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1182\/blood.V99.4.1109","volume":"99","author":"UE Hopken","year":"2002","unstructured":"Hopken UE, Foss HD, Meyer D, Hinz M, Leder K, Stein H et al. Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood 2002; 99: 1109\u20131116.","journal-title":"Blood"},{"key":"BFleu2010118_CR35","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1182\/blood-2003-09-3103","volume":"104","author":"L Trentin","year":"2004","unstructured":"Trentin L, Cabrelle A, Facco M, Carollo D, Miorin M, Tosoni A et al. Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 2004; 104: 502\u2013508.","journal-title":"Blood"},{"key":"BFleu2010118_CR36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V112.11.785.785","volume":"112","author":"A Novak","year":"2008","unstructured":"Novak A, Akasaka T, Manske M, Gupta M, Witzig T, Dyer MJS et al. Elevated expression of GPR34 and its association with a novel translocation t(X;14)(p11;q32) involving IGHS and GPR34 in MALT lymphoma. Blood 2008; 112: 785, Abstract 2251.","journal-title":"Blood"},{"key":"BFleu2010118_CR37","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1136\/gut.2004.061663","volume":"55","author":"MQ Du","year":"2006","unstructured":"Du MQ, Atherton JC . Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut 2006; 55: 886\u2013893.","journal-title":"Gut"},{"key":"BFleu2010118_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.dld.2008.02.031","volume":"40","author":"D McNamara","year":"2008","unstructured":"McNamara D, El Omar E . Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions. Dig Liver Dis 2008; 40: 504\u2013509.","journal-title":"Dig Liver Dis"},{"key":"BFleu2010118_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH811>3.0.CO;2-Z","volume":"193","author":"D de Jong","year":"2001","unstructured":"de Jong D, Vyth-Dreese F, Dellemijn T, Verra N, Ruskone-Fourmestraux A, Lavergne-Slove A et al. Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma. J Pathol 2001; 193: 318\u2013324.","journal-title":"J Pathol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2010118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010118","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:34:18Z","timestamp":1648733658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2010118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,3]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["BFleu2010118"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.118","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,3]]},"assertion":[{"value":"4 November 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}